Vagaries of the ELISpot assay : specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines

Copyright © 2015 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 157(2015), 2 vom: 15. Apr., Seite 216-25
1. Verfasser: Fuchs, Yannick F (VerfasserIn)
Weitere Verfasser: Jainta, Gregor W, Kühn, Denise, Wilhelm, Carmen, Weigelt, Marc, Karasinsky, Anne, Upadhyaya, Bhaskar, Ziegler, Anette-G, Bonifacio, Ezio
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2015
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Autoantigen CD8(+) T cells Diabetes ELISpot MHC class I HLA-A*02:01 antigen HLA-A2 Antigen Histocompatibility Antigens Class I mehr... Interferon-gamma 82115-62-6
Beschreibung
Zusammenfassung:Copyright © 2015 Elsevier Inc. All rights reserved.
Quantification of antigen-specific CD8(+) T cells is important for monitoring infection, vaccination, and response to therapy in cancer and immune-mediated diseases. Cytokine enzyme-linked-immunospot (ELISpot) assays are often used for this purpose. We found that substantial spot formation in IFNγ ELISpot assays occurred independently of CD8(+) T cells even when classical MHC class I restricted peptides are used for stimulation. Using fractionated cells and intracellular cytokine staining, the non-CD8(+) T cell IFNγ production was attributed to the CD4(+) T cell fraction. We therefore refined a cell line-based ELISpot assay combining HLA-A*0201 expressing K562 cells for antigen presentation with purified CD8(+) T cells and demonstrated that it specifically detected CD8(+) T cell responses with detection limits comparable to traditional ELISpot assays and dextramer-based quantification. The assay was further adapted to whole antigen responses with antigen (pre-proinsulin)-expressing HLA-A*0201K562 cells. Thus, we revealed and corrected a weak spot of the CD8(+) ELISpot assay
Beschreibung:Date Completed 29.06.2015
Date Revised 27.04.2015
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2015.02.012